Laetitia Gosetto

Laetitia Gosetto

Auto-generated profile, based on publicly available information

Laetitia Gosetto

Division of Medical Information Sciences, Geneva University Hospitals, Geneva, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in JMIR Human Factors
Verified
Journal Article
Open access
JSJohan N. Siebert
Johan N. Siebert
LGLaëtitia Gosetto
Laëtitia Gosetto
MSManon Sauvage
Manon Sauvage
LBLaurie Bloudeau
Laurie Bloudeau
Laurent SuppanLaurent Suppan
Laurent Suppan
PGPedAMINES Prehospital Group
PedAMINES Prehospital Group
Background: Mobile apps are increasingly being used in various domains of medicine. Few are evidence-based, and their benefits can only be achieved if end users intend to adopt and use them. To date, only a small fraction of mobile apps have published data on their field usability and end user acceptance results, especially in emergency medicine. Objective: This study aims to determine the usability and acceptance of an evidence-based mobile app while safely preparing emergency drugs at the point of care during pediatric in- and out-of-hospital cardiopulmonary resuscitations by frontline caregivers. Methods: In 2 multicenter randomized controlled parent trials conducted at 6 pediatric emergency departments from March 1 to December 31, 2017, and 14 emergency medical services from September 3, 2019, to January 21, 2020, the usability and technology acceptance of the PedAMINES (Pediatric Accurate Medication in Emergency Situations) app were evaluated among skilled pediatric emergency nurses and advanced paramedics when preparing continuous infusions of vasoactive drugs and direct intravenous emergency drugs at pediatric dosages during standardized, simulation-based, pediatric in- and out-of-hospital cardiac arrest scenarios, respectively. Usability was measured using the 10-item System Usability Scale. A 26-item technology acceptance self-administered survey (5-point Likert-type scales), adapted from the Unified Theory of Acceptance and Use of Technology model, was used to measure app acceptance and intention to use. Results: All 100% (128/128) of nurses (crossover trial) and 49.3% (74/150) of paramedics (parallel trial) were assigned to the mobile app. Mean total scores on the System Usability Scale were excellent and reached 89.5 (SD 8.8; 95% CI 88.0-91.1) for nurses and 89.7 (SD 8.7; 95% CI 87.7-91.7) for paramedics. Acceptance of the technology was very good and rated on average >4.5/5 for 5 of the 8 independent constructs evaluated. Only the image construct scored between 3.2 and 3.5 by both participant populations. Conclusions: The results provide evidence that dedicated mobile apps can be easy to use and highly accepted at the point of care during in- and out-of-hospital cardiopulmonary resuscitations by frontline emergency caregivers. These findings can contribute to the implementation and valorization of studies aimed at evaluating the usability and acceptance of mobile apps in the field by caregivers, even in critical situations. Trial Registration: ClinicalTrials.gov NCT03021122; https://clinicaltrials.gov/ct2/show/NCT03021122. ClinicalTrials.gov NCT03921346; https://clinicaltrials.gov/ct2/show/NCT03921346 International Registered Report Identifier (IRRID): RR2-10.1186/s13063-019-3726-4

2 September 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
Giulio AmabiliGiulio Amabili
Giulio Amabili
EMElvira Maranesi
Elvira Maranesi
AMArianna Margaritini
Arianna Margaritini
ABAnna Rita Bonfigli
Anna Rita Bonfigli
EFElisa Felici
Elisa Felici
RBRoberta Bevilacqua
Roberta Bevilacqua
Background: Dementia is challenging society in terms of the quality of life, the costs of health care systems, and caregivers’ burden. Dementia is often preceded by a status of mild cognitive impairment (MCI), during which a healthy lifestyle and cognitive therapy seem to be effective in counteracting the decline. Objective: The engAGE (Managing Cognitive Decline Through Theatre Therapy, Artificial Intelligence, and Social Robot–Driven Interventions) project aimed to build a technological platform to counteract cognitive decline in older adults with MCI through both cognitive therapy and lifestyle management. Methods: The engAGE platform was built around the social robot Pepper, which provides cognitive therapy. An activity tracker and a mobile app were also integrated within the platform to help older adults with MCI monitor their sleep and physical activity, in addition to offering cognitive games at home. The proof of concept (PoC) of engAGE was designed as a 6-month long randomized controlled trial (RCT) aimed to test the solution in three European countries: Italy, Switzerland, and Norway. During this period, under the supervision of a psychologist or a therapist, Pepper provided cognitive therapy on a weekly basis at health care or daycare facilities. In parallel, the use of the mobile app and the activity tracker was recommended on a daily basis. Participants were recruited through health care institutions and care organizations and evaluated through face-to-face interviews. The primary interest of the study was to assess the impact of engAGE on cognitive capacity through the Montreal Cognitive Assessment (MoCA) and the Memory Assessment Clinic Questionnaire (MAC-Q). In addition, changes in social engagement and quality of life were measured through the University of California, Los Angeles (UCLA) Loneliness Scale and the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS). The PoC also focused on the acceptability and usability of engAGE, evaluated through the System Usability Scale (SUS) and the Unified Theory of Acceptance and Use of Technology (UTAUT) questionnaire. In addition, data were collected regarding the frequency of weekly sessions and access to the mobile app, as well as activity tracker measurements. Results: Data collection commenced in November 2023 and finished in July 2024, with the enrollment of 49 older adults with MCI (n=40, 81.6%, assigned to the experimental group [EG] and n=9, 18.4%, to the control group [CG]) conducted from October 2023 to April 2024. Data analysis was concluded in November 2024, and results will be published by 2026. Conclusions: The engAGE PoC represents an innovative study focused on the impact of a technology-based multidomain intervention designed for older adults with MCI that aimed to counteract cognitive decline through cognitive training, as well as improvement in terms of the quality of life, social engagement, physical activity, and sleep quality of primary end users. Trial Registration: ClinicalTrials.gov NCT06302686; https://clinicaltrials.gov/study/NCT06302686 International Registered Report Identifier (IRRID): RR1-10.2196/67601

19 August 2025 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
LGLaëtitia Gosetto
Laëtitia Gosetto
GFGilles Falquet
Gilles Falquet
Frederic EhrlerFrederic Ehrler
Frederic Ehrler
The World Health Organization identifies unhealthy behaviors, such as smoking, as significant risk factors contributing to mortality and morbidity, underscoring the necessity to adopt healthier habits. The increasing prevalence of health applications (apps) presents opportunities for promoting healthier lifestyles. Notably, personalized mobile health (mHealth) interventions can enhance user engagement and their effectiveness. Our scoping review aims to contribute to guide the personalization of mHealth interventions for health behavior change by defining which mechanisms should be favored for a given user profile. Online databases were searched to identify articles published between 2008 and 2024 describing the topic of personalization, behavior change apps, and mobile app mechanisms. Of 1806 articles identified, 18 articles were retained. We then categorized the mechanisms and user profiles described in the selected articles into existing taxonomies. Finally, the relationship between the user profiles and mechanisms were reported. The four user profiles identified included personality and gamer profiles. Twenty-one mechanisms extracted from the articles were categorized as behavioral change techniques, gamification, or mobile app mechanisms, with limited numbers of preference relations between mechanisms and user profiles. The relation matrix was not complete and covered only 51% of possible relations: game mechanisms, 30%; behavioral change techniques, 16%; and app mechanisms, 5%. Two user profiles, the Big Five (18%) and Hexad scale (20%), covered 38% of relations, whereas the two remaining user profiles contributed to the remaining 13%. Social mechanisms, including competition, cooperation, and social comparison, exhibit strong connections to user profiles and are pivotal in persuasive system design. Self-efficacy theory links mechanisms such as self-monitoring, social persuasion, and rewards to behavior change. However, only 51% of potential relationships between profiles and mechanisms were identified. Adapting mHealth content based on user profiles requires reliable personality assessments and privacy-conscious data collection to enable personalized, profile-specific interventions for improved outcomes.

5 January 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
LGLaetitia Gosetto
Laetitia Gosetto
Marta PittavinoMarta Pittavino
Marta Pittavino
GFGilles Falquet
Gilles Falquet
Frederic EhrlerFrederic Ehrler
Frederic Ehrler
Background: Mobile health apps have the potential to motivate people to adopt healthier behavior, but many fail to maintain this behavior over time. However, it has been suggested that long-term adherence can be improved by personalizing the proposed interventions. Based on the literature, we created a conceptual framework for selecting appropriate functionalities according to the user's profile. Objective: This cross-sectional study aims to investigate if the relationships linking functionalities and profiles proposed in our conceptual framework are confirmed by user preferences. Methods: A web-based questionnaire comprising several sections was developed to determine the mobile app functionalities most likely to promote healthier behavior. First, participants completed questionnaires to define the user profile (Big Five Inventory-10, Hexad Scale, and perception of the social norm using dimensions of the Theory of Planned Behavior). Second, participants were asked to select the 5 functionalities they considered to be the most relevant to motivate healthier behavior and to evaluate them on a score ranging from 0 to 100. We will perform logistic regressions with the selected functionalities as dependent variables and with the 3 profile scales as predictors to allow us to understand the effect of the participants’ scores on each of the 3 profile scales on the 5 selected functionalities. In addition, we will perform logistic ordinal regressions with the motivation score of the functionalities chosen as dependent variables and with scores of the 3 profile scales as predictors to determine whether the scores on the different profile scales predict the functionality score. Results: Data collection was conducted between July and December 2021. Analysis of responses began in January 2022, with the publication of results expected by the end of 2022. Conclusions: This study will allow us to validate our conceptual model by defining the preferred functionalities according to user profiles. International Registered Report Identifier (IRRID): RR1-10.2196/38603

22 August 2024
Verified
Book Chapter
Open access
PDF file
LGLaëtitia Gosetto
Laëtitia Gosetto
JGJulie Guebey
Julie Guebey
CLChristian Lovis
Christian Lovis
Ionut AnghelIonut Anghel
Ionut Anghel
Tudor CioaraTudor Cioara
Tudor Cioara
Heart failure is the leading reason for seniors being admitted to hospitals. Over half of the elderly individuals diagnosed with heart failure find themselves readmitted to hospitals within a span of six months. This recurrence is associated with inadequate adherence to medical treatment and recommendations, underscoring the necessity for support systems that aid seniors in better adhering to post-hospitalization instructions. The objective of this study is to evaluate the usability, usefulness and added value of the core functionalities within the H2HCare Ambient Assisted Living developed system that was evaluated with 11 participants over a long field trial of three months. Our assessment encompassed the examination of their Quality of Life as well as the usability and efficacy of the system. Overall, participants reported finding the system user-friendly, beneficial, and conducive to enhanced disease management. Improvements include tailoring the alarm system to patient standards and using a questionnaire to assess situation urgency.

16 October 2024 in JMIR Preprints
Verified
Preprint
Open access
Giulio AmabiliGiulio Amabili
Giulio Amabili
EMElvira Maranesi
Elvira Maranesi
AMArianna Margaritini
Arianna Margaritini
ABAnna Rita Bonfigli
Anna Rita Bonfigli
EFElisa Felici
Elisa Felici
RBRoberta Bevilacqua
Roberta Bevilacqua
BACKGROUND Dementia is challenging society in terms of the quality of life, the costs of health care systems, and caregivers’ burden. Dementia is often preceded by a status of mild cognitive impairment (MCI), during which a healthy lifestyle and cognitive therapy seem to be effective in counteracting the decline. OBJECTIVE The engAGE (Managing Cognitive Decline Through Theatre Therapy, Artificial Intelligence, and Social Robot–Driven Interventions) project aimed to build a technological platform to counteract cognitive decline in older adults with MCI through both cognitive therapy and lifestyle management. METHODS The engAGE platform was built around the social robot Pepper, which provides cognitive therapy. An activity tracker and a mobile app were also integrated within the platform to help older adults with MCI monitor their sleep and physical activity, in addition to offering cognitive games at home. The proof of concept (PoC) of engAGE was designed as a 6-month long randomized controlled trial (RCT) aimed to test the solution in three European countries: Italy, Switzerland, and Norway. During this period, under the supervision of a psychologist or a therapist, Pepper provided cognitive therapy on a weekly basis at health care or daycare facilities. In parallel, the use of the mobile app and the activity tracker was recommended on a daily basis. Participants were recruited through health care institutions and care organizations and evaluated through face-to-face interviews. The primary interest of the study was to assess the impact of engAGE on cognitive capacity through the Montreal Cognitive Assessment (MoCA) and the Memory Assessment Clinic Questionnaire (MAC-Q). In addition, changes in social engagement and quality of life were measured through the University of California, Los Angeles (UCLA) Loneliness Scale and the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS). The PoC also focused on the acceptability and usability of engAGE, evaluated through the System Usability Scale (SUS) and the Unified Theory of Acceptance and Use of Technology (UTAUT) questionnaire. In addition, data were collected regarding the frequency of weekly sessions and access to the mobile app, as well as activity tracker measurements. RESULTS Data collection commenced in November 2023 and finished in July 2024, with the enrollment of 49 older adults with MCI (n=40, 81.6%, assigned to the experimental group [EG] and n=9, 18.4%, to the control group [CG]) conducted from October 2023 to April 2024. Data analysis was concluded in November 2024, and results will be published by 2026. CONCLUSIONS The engAGE PoC represents an innovative study focused on the impact of a technology-based multidomain intervention designed for older adults with MCI that aimed to counteract cognitive decline through cognitive training, as well as improvement in terms of the quality of life, social engagement, physical activity, and sleep quality of primary end users. CLINICALTRIAL ClinicalTrials.gov NCT06302686; https://clinicaltrials.gov/study/NCT06302686 INTERNATIONAL REGISTERED REPORT RR1-10.2196/67601